Google Debug Seeks EPA OK to Release 32M Wolbachia Mosquitoes

Google’s Debug unit filed an application with the U.S. Environmental Protection Agency seeking permission to release up to 32 million Wolbachia-infected male mosquitoes in Florida over two years. The filing appears under docket EPA-HQ-OPP-2025-3951 and includes a parallel proposal for California.

The Florida plan would permit up to 16 million males in year one and 16 million in year two. The public comment period closes June 5; after that deadline the EPA will decide whether to approve, deny, or approve with conditions the proposed experimental use.

The application identifies the insects as male Culex quinquefasciatus carrying Wolbachia pipientis strain wAlbB. Culex quinquefasciatus, commonly called the southern house mosquito, can transmit West Nile virus.

The Wolbachia method relies on cytoplasmic incompatibility: when infected males mate with uninfected females, most resulting eggs do not hatch. Repeated releases are intended to lower local mosquito numbers.

Only males would be released; male mosquitoes do not bite or transmit disease. The filing notes sex separation at scale is a technical challenge and describes use of artificial intelligence, automation and robotics to sort insects by sex, rear large numbers of males and coordinate systematic releases.

Debug cited results from its Project Wolbachia partnership in Singapore, which targets Aedes aegypti, the primary dengue carrier. Official program data show 80 to 90 percent suppression of Aedes populations in treated areas and more than 70 percent reduction in dengue risk after sustained releases. The company reports it releases more than 10 million male Wolbachia mosquitoes weekly at that site.

Randomized controlled trials in Vietnam and Australia found dengue cases fell about 77 percent in areas where Wolbachia established. Research on Wolbachia in Aedes aegypti has shown reduced replication of dengue, Zika and chikungunya viruses in treated populations.

The EPA classifies Wolbachia releases as a biological control under federal pesticide law, which triggers regulated experimental-use review and public input. The agency will consider potential ecological effects, human health factors and the proposed safeguards for production, sex separation and release.

If the EPA issues an experimental-use permit, the trial would operate under federal conditions and could provide field data for a future product registration. Any approval could include monitoring, reporting or operational limits. Public comments submitted before June 5 will be part of the EPA’s review record and will inform the agency’s decision on whether the two-year field tests may proceed in Florida and California.